Heparin and low-molecular-weight heparin - PubMed (original) (raw)
Review
Heparin and low-molecular-weight heparin
Elaine Gray et al. Thromb Haemost. 2008 May.
Abstract
Heparin is one of the oldest biological medicines, and has an established place in the prevention and treatment of venous thrombosis. Low-molecular-weight heparins (LMWH) have been developed by several manufacturers and have advantages in terms of pharmacokinetics and convenience of administration. They have been shown to be at least as effective and safe as unfractionated heparin and have replaced the latter in many indications. In this article the chemistry, mechanisms of action, measurement of anticoagulant activities, and clinical status of heparin and LMWH are reviewed.
Similar articles
- Heparin and low molecular weight heparin in thrombosis and beyond.
Mousa SA. Mousa SA. Curr Opin Investig Drugs. 2002 Aug;3(8):1181-6. Curr Opin Investig Drugs. 2002. PMID: 12211411 Review. - Changing trends in anti-coagulant therapies. Are heparins and oral anti-coagulants challenged?
Fareed J, Iqbal O, Cunanan J, Demir M, Wahi R, Clarke M, Adiguzel C, Bick R. Fareed J, et al. Int Angiol. 2008 Jun;27(3):176-92. Int Angiol. 2008. PMID: 18506123 Review. - Low-molecular-weight heparin in the treatment of deep venous thrombosis.
Hauer KE. Hauer KE. West J Med. 1998 Oct;169(4):240-4. West J Med. 1998. PMID: 9795594 Free PMC article. - Direct inhibitors of coagulation proteins - the end of the heparin and low-molecular-weight heparin era for anticoagulant therapy?
Laux V, Perzborn E, Heitmeier S, von Degenfeld G, Dittrich-Wengenroth E, Buchmüller A, Gerdes C, Misselwitz F. Laux V, et al. Thromb Haemost. 2009 Nov;102(5):892-9. doi: 10.1160/TH09-02-0134. Thromb Haemost. 2009. PMID: 19888525 Review.
Cited by
- Low-Molecular-Weight Heparins: Reduced Size Particulate Systems for Improved Therapeutic Outcomes.
Akhtar F, Wan X, Wu G, Kesse S, Wang S, He S. Akhtar F, et al. Molecules. 2018 Jul 18;23(7):1757. doi: 10.3390/molecules23071757. Molecules. 2018. PMID: 30021958 Free PMC article. Review. - The interaction between oxytocin and heparin.
Schnur E, Rudd TR. Schnur E, et al. RSC Adv. 2020 Jul 29;10(47):28300-28313. doi: 10.1039/d0ra04204h. eCollection 2020 Jul 27. RSC Adv. 2020. PMID: 35519099 Free PMC article. - The Auxiliary Role of Heparin in Bone Regeneration and its Application in Bone Substitute Materials.
Wang J, Xiao L, Wang W, Zhang D, Ma Y, Zhang Y, Wang X. Wang J, et al. Front Bioeng Biotechnol. 2022 May 12;10:837172. doi: 10.3389/fbioe.2022.837172. eCollection 2022. Front Bioeng Biotechnol. 2022. PMID: 35646879 Free PMC article. Review. - Section 5: Dialysis Interventions for Treatment of AKI.
[No authors listed] [No authors listed] Kidney Int Suppl (2011). 2012 Mar;2(1):89-115. doi: 10.1038/kisup.2011.35. Kidney Int Suppl (2011). 2012. PMID: 25018921 Free PMC article. No abstract available. - Thromboprophylaxis in multiple myeloma: a case-based review with practical guidelines.
Charalampous C, Shah D, Kumar S, Chakraborty R. Charalampous C, et al. Ann Hematol. 2024 Oct;103(10):3881-3888. doi: 10.1007/s00277-024-05733-9. Epub 2024 Apr 17. Ann Hematol. 2024. PMID: 38630132 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical